Abstract
Purpose As large analyses merge data across sites, a deeper understanding of variance in statistical assessment across the sources of data becomes critical for valid analyses. Diffusion tensor imaging (DTI) exhibits spatially varying and correlated noise, so care must be taken with distributional assumptions. Here we characterize the role of physiology, subject compliance, and the interaction of subject with the scanner in the understanding of DTI variability, as modeled in spatial variance of derived metrics in homogeneous regions.
Approach We analyze DTI data from 1035 subjects in the Baltimore Longitudinal Study of Aging (BLSA), with ages ranging from 22.4 to 103 years old. For each subject, up to 12 longitudinal sessions were conducted. We assess variance of DTI scalars within regions of interest (ROIs) defined by four segmentation methods and investigate the relationships between the variance and covariates, including baseline age, time from the baseline (referred to as “interval”), motion, sex, and whether it is the first scan or the second scan in the session.
Results Covariate effects are heterogeneous and bilaterally symmetric across ROIs. Inter-session interval is positively related (p ≪ 0.001) to FA variance in the cuneus and occipital gyrus, but negatively (p ≪ 0.001) in the caudate nucleus. Males show significantly (p ≪ 0.001) higher FA variance in the right putamen, thalamus, body of the corpus callosum, and cingulate gyrus. In 62 out of 176 ROIs defined by the Eve type-1 atlas, an increase in motion is associated (p < 0.05) with a decrease in FA variance. Head motion increases during the rescan of DTI (Δμ = 0.045 millimeters per volume).
Conclusions The effects of each covariate on DTI variance, and their relationships across ROIs are complex. Ultimately, we encourage researchers to include estimates of variance when sharing data and consider models of heteroscedasticity in analysis. This work provides a foundation for study planning to account for regional variations in metric variance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by the National Institute of Health through grants 1R01EB017230-01A1 (Bennett A. Landman), 5-K01-EB032898-02 (Kurt Schilling), 1U24AG074855-01 (Timothy J. Hohman), and ViSE/VICTR VR3029 and by the Intramural Research Program of the National Institute on Aging, NIH. This work was conducted in part using the resources of the Advanced Computing Center for Research and Education at Vanderbilt University, Nashville, TN. We appreciate the National Institute of Health S10 Shared Instrumentation grant 1S10OD020154-01 (Smith), and grant 1S10OD023680-01 (Vanderbilt's High-Performance Computer Cluster for Biomedical Research). The Vanderbilt Institute for Clinical and Translational Research (VICTR) is funded by the National Center for Advancing Translational Sciences (NCATS) Clinical Translational Science Award (CTSA) Program, Award Number 5UL1TR002243-03. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Vanderbilt IRB waived for de-identified access. (IRB #172072, PI: Bennett A. Landman)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵1 Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf
↵2 Data used in preparation of this article were derived from BIOCARD study data, supported by grant U19 – AG033655 from the National Institute on Aging. The BIOCARD study team did not participate in the analysis or writing of this report, however, they contributed to the design and implementation of the study. A listing of BIOCARD investigators may be accessed at: https://www.biocard-se.org/public/Core%20Groups.html
Included ADNI and BIOCARD datasets for validation. Added results from the additional experiments in response to the revisions required by the reviewers of the journal.
Data Availability
All data used in the present work are available upon request to the Baltimore Longitudinal Study of Aging (BLSA), the Alzheimer's Disease Neuroimaging Initiative (ADNI), and the BIOCARD study.
https://www.biocard-se.org/public/BIOCARD%20Home%20Page.html
